TLA

Commerzbank increases net profit for 2023 to €2.2 billion – Strategy is delivering

Retrieved on: 
Thursday, February 15, 2024
Rote, Commerzbank, NPE, German Finance Agency, DACH, Bank, TLA, Growth, ECM, Equity capital markets, Risk, Private, Central bank, MBank, European Central Bank, ODDO BHF, PSBC, RWA, Tax, Policy, Common equity, AT1, Annual, Executive officer, Research, Environment, Partnership, Cryptocurrency

On this basis, we will achieve a further increase in net profit for the current year”, said CEO Manfred Knof.

Key Points: 
  • On this basis, we will achieve a further increase in net profit for the current year”, said CEO Manfred Knof.
  • Net interest income rose by a third to €8.368 billion (2022: €6.459 billion), while net commission income was slightly down at €3.386 billion (2022: €3.519 billion).
  • Net profit also rose accordingly: compared to the previous year, net profit after taxes and minority interests increased by 55% to €2.224 billion (2022: €1.435 billion).
  • Revenues amounted to €1.106 billion (Q3 2023: €1.171 billion); the operating result totalled €508 million (Q3 2023: €644 million).

EQS-News: Commerzbank increases net profit for 2023 to €2.2 billion – Strategy is delivering

Retrieved on: 
Thursday, February 15, 2024
Rote, Commerzbank, NPE, German Finance Agency, DACH, Bank, TLA, Growth, ECM, Equity capital markets, Risk, Private, Central bank, MBank, European Central Bank, ODDO BHF, PSBC, RWA, Tax, Policy, Common equity, AT1, Annual, Executive officer, Research, Environment, Partnership, Cryptocurrency

On this basis, we will achieve a further increase in net profit for the current year”, said CEO Manfred Knof.

Key Points: 
  • On this basis, we will achieve a further increase in net profit for the current year”, said CEO Manfred Knof.
  • Net interest income rose by a third to €8.368 billion (2022: €6.459 billion), while net commission income was slightly down at €3.386 billion (2022: €3.519 billion).
  • Net profit also rose accordingly: compared to the previous year, net profit after taxes and minority interests increased by 55% to €2.224 billion (2022: €1.435 billion).
  • Revenues amounted to €1.106 billion (Q3 2023: €1.171 billion); the operating result totalled €508 million (Q3 2023: €644 million).

TripleLift's 2023 Snapshot: A Year of Effectiveness & Results for Advertisers

Retrieved on: 
Thursday, December 21, 2023
Samsung, Atmosphere, Depreciation, Corporate social responsibility, TLA, AAPI, Ecosystem, Partnership, The Home Depot, Comscore, GHG, Verizon Communications, CPM, Female, Amazon, Woman, UNREP, LATAM, Carbon accounting, DIRECTV, Canadian Tire money, CPC, Yoy, Patch, Advertising, Trillion, Carbon, MENA, CTV, Online shopping

NEW YORK, Dec. 21, 2023 /PRNewswire/ -- As 2023 draws to a close, TripleLift, the ad tech platform elevating digital advertising across every screen, wraps a 2023-year marked by innovation, strategic partnerships, and a commitment to economic inclusion and sustainability. With the launch of first-party data solution TripleLift Audiences, along with partnerships that bolster the offering, the ad tech platform made significant leaps in demonstrating effectiveness and delivering results for advertisers and publishers.

Key Points: 
  • With the launch of first-party data solution TripleLift Audiences, along with partnerships that bolster the offering, the ad tech platform made significant leaps in demonstrating effectiveness and delivering results for advertisers and publishers.
  • The launch of TripleLift Audiences (TLA) in 2023 is more than a technological advancement; it's a paradigm shift in how advertisers and publishers understand the power of first-party data.
  • September marked the release of the industry's first-ever large-scale test results showing that its recently launched targeting solution is effective across the web, including in cookie-constrained environments.
  • With 28,600 domains already available, TLA has delivered a remarkable CPM increase of 26% for publishers and a 33% lower cost-per-click (CPC) for advertisers.

TripleLift's 2023 Snapshot: A Year of Effectiveness & Results for Advertisers

Retrieved on: 
Thursday, December 21, 2023
Samsung, Atmosphere, Depreciation, Corporate social responsibility, TLA, AAPI, Ecosystem, Partnership, The Home Depot, Comscore, GHG, Verizon Communications, CPM, Female, Amazon, Woman, UNREP, LATAM, Carbon accounting, DIRECTV, Canadian Tire money, CPC, Yoy, Patch, Advertising, Trillion, Carbon, MENA, CTV, Online shopping

NEW YORK, Dec. 21, 2023 /PRNewswire/ -- As 2023 draws to a close, TripleLift, the ad tech platform elevating digital advertising across every screen, wraps a 2023-year marked by innovation, strategic partnerships, and a commitment to economic inclusion and sustainability. With the launch of first-party data solution TripleLift Audiences, along with partnerships that bolster the offering, the ad tech platform made significant leaps in demonstrating effectiveness and delivering results for advertisers and publishers.

Key Points: 
  • With the launch of first-party data solution TripleLift Audiences, along with partnerships that bolster the offering, the ad tech platform made significant leaps in demonstrating effectiveness and delivering results for advertisers and publishers.
  • The launch of TripleLift Audiences (TLA) in 2023 is more than a technological advancement; it's a paradigm shift in how advertisers and publishers understand the power of first-party data.
  • September marked the release of the industry's first-ever large-scale test results showing that its recently launched targeting solution is effective across the web, including in cookie-constrained environments.
  • With 28,600 domains already available, TLA has delivered a remarkable CPM increase of 26% for publishers and a 33% lower cost-per-click (CPC) for advertisers.

Commerzbank lays foundation for further strategic plan with strong 9M net profit – targeting RoTE of more than 11% in 2027

Retrieved on: 
Wednesday, December 27, 2023
AT1, Private, TLA, Bank, European Central Bank, MBank, Environment, Commerzbank, PSBC, FX, Face, Risk, Central bank, Economic development, Annual, Yellow-fin, Common equity, German Finance Agency, MDA, Rote, Growth, Wealth management, Investment, Capital market, NPE

The Bank has almost achieved the key targets of its “Strategy 2024” and has laid a strong foundation for the targeted higher pay-out.

Key Points: 
  • The Bank has almost achieved the key targets of its “Strategy 2024” and has laid a strong foundation for the targeted higher pay-out.
  • By 2027, the revenue base is to be further expanded through consistent customer orientation and profitability is to be continuously increased.
  • The Bank’s financial steering will continue to be based on the cost-income ratio, which is planned to improve to around 55% by 2027.
  • For 2022 to 2024, the plan is still to distribute a total of €3 billion to shareholders through dividends and share buy-backs.

Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium

Retrieved on: 
Thursday, November 16, 2023
Cardiology, Biotechnology, Other Health, Health, General Health, Other Science, Medical Devices, Research, Hospitals, Science, Clinical Trials, Paclitaxel, TLA, Safety, PAD, Clinical trial, Patient, DCB, Thrombosis, Death, Freedom, Popliteal artery, Pharmaceutical industry, Czech Republic

Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that 36-month data from its TRANSCEND clinical trial was presented by Dr. Peter A. Schneider at the 50th Annual VEITH Symposium in New York, New York.

Key Points: 
  • Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that 36-month data from its TRANSCEND clinical trial was presented by Dr. Peter A. Schneider at the 50th Annual VEITH Symposium in New York, New York.
  • The TRANSCEND trial is a prospective, multi-center, single-blind, randomized, controlled trial to assess the safety and efficacy of the SurVeil™ drug coated balloon (DCB) versus the IN.PACT® Admiral® DCB for treatment of superficial femoral and proximal popliteal artery lesions.
  • The primary efficacy endpoint is 12-month primary patency, defined as freedom from binary restenosis or clinically driven target lesion revascularization (CD-TLR).
  • “The TRANSCEND 36-Month data continues to demonstrate safe and effective performance of the SurVeil DCB.

Graphite One Delivers Synthetic Graphite Material Key to Accelerating its Path to Anode Material Production

Retrieved on: 
Tuesday, December 12, 2023
TLA, Graphite, Recycling, IRA, Bering Straits Native Corporation, Inflation, Ampere-hour, DPA, Growth, EV, Dollar for Dollar, Aluminium, Sunrise

Battery Anode Material Supply

Key Points: 
  • Battery Anode Material Supply
    VANCOUVER, BC, Dec. 12, 2023 /PRNewswire/ - Graphite One Inc. (TSXV: GPH) OTCQX: GPHOF) ("Graphite One" or the "Company") is pleased to announce the delivery of synthetic graphite anode material samples for analysis by U.S.-based global end-users.
  • Graphite One's updated plan is to first construct a synthetic anode material production facility to produce a range of synthetic anode materials.
  • A natural graphite anode material production line would later be added, in time to receive natural graphite from Graphite Ones's Graphite Creek deposit near Nome, Alaska once it is permitted and operating.
  • Sunrise had previously prepared natural graphite anode materials for Graphite One using Graphite Creek graphite concentrate.

EQS-News: Commerzbank lays foundation for further strategic plan with strong 9M net profit – targeting RoTE of more than 11% in 2027

Retrieved on: 
Thursday, December 14, 2023
Yellow-fin, Risk, Private, AT1, German Finance Agency, European Central Bank, Face, Annual, NPE, PSBC, Common equity, Wealth management, MBank, Environment, Commerzbank, FX, MDA, Growth, Economic development, Bank, Capital market, CET, Rote, Central bank, TLA, Investment, Security (finance), Cryptocurrency, Retail, Life insurance, Video game, Q3

The Bank has almost achieved the key targets of its “Strategy 2024” and has laid a strong foundation for the targeted higher pay-out.

Key Points: 
  • The Bank has almost achieved the key targets of its “Strategy 2024” and has laid a strong foundation for the targeted higher pay-out.
  • By 2027, the revenue base is to be further expanded through consistent customer orientation and profitability is to be continuously increased.
  • The Bank’s financial steering will continue to be based on the cost-income ratio, which is planned to improve to around 55% by 2027.
  • For 2022 to 2024, the plan is still to distribute a total of €3 billion to shareholders through dividends and share buy-backs.

Quantifying Genetic Stability and Quality Control of Multiple Integrations of Orthogonal Transposases, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Wednesday, October 25, 2023
Business development, LEAP, NGS, CHO, ATUM, Doctor of Philosophy, Gene, Metabolism, TLA, Vaccine

TORONTO, Oct. 25, 2023 /PRNewswire-PRWeb/ -- Discover a groundbreaking webinar delving into transposase-mediated genome engineering, genetic quality control (QC) and stability of orthogonal transposons in the generation of cell lines with Leap-In Transposase® technology. Genes encoding biotherapeutic proteins can stably be introduced into mammalian genomes by several different approaches. The transposon-based platform avoids major challenges presented by random integration or viral-based delivery systems.

Key Points: 
  • In this free webinar, learn about transposase-mediated genome engineering, genetic quality control and ensuring the genetic stability of orthogonal transposons in the generation of cell lines with Leap-In Transposase® technology.
  • TORONTO, Oct. 25, 2023 /PRNewswire-PRWeb/ -- Discover a groundbreaking webinar delving into transposase-mediated genome engineering, genetic quality control (QC) and stability of orthogonal transposons in the generation of cell lines with Leap-In Transposase® technology.
  • Furthermore, by comparing the TLA data of different timepoints they were able to evaluate the genetic stability and integrity of the transposons.
  • Join this webinar to learn about transposase-mediated genome engineering, genetic quality control and ensuring the genetic stability of orthogonal transposons in the generation of cell lines with Leap-In Transposase® technology.

Commerzbank with strong first half of the year – net profit increased by almost 50% to €1.1 billion

Retrieved on: 
Friday, August 4, 2023
NPE, German Finance Agency, European Central Bank, Air Commerz, Private, TLA, RWA, Common equity, European Court of Justice, Commerzbank, MBank, Central bank, Semiconductor Manufacturing International Corporation, Share repurchase, European Court, Risk, ECB, AT1, ECJ, PSBC, Growth, Bank, MDA, Rote, Cryptocurrency, Renewable energy, Real estate, Video game

Revenues increased by 8.7% to €2.629 billion in the second quarter (Q2 2022: €2.420 billion) despite the additional burdens from the Swiss franc mortgages at the Polish subsidiary mBank.

Key Points: 
  • Revenues increased by 8.7% to €2.629 billion in the second quarter (Q2 2022: €2.420 billion) despite the additional burdens from the Swiss franc mortgages at the Polish subsidiary mBank.
  • Operating expenses increased to €1.481 billion (Q2 2022: €1.423 billion) as a result of earlier increases of accruals for variable compensation and general salary increases.
  • Thanks to the positive stock market performance, the securities volume increased to €208 billion (Q1 2023: €202 billion).
  • Deposit volumes remained stable at €96 billion (Q1 2023: €95 billion), with increased interest rates gradually being passed on.